Related Tags >> FDA Phase III alpharma milestones

painkiller News

Most Popular painkiller Story

Alpharma sub inks $202M deal for pain drug

September 6, 2007 — 6:59am ET

A subsidiary of Alpharma has agreed to pay Germany's IDEA up to $202 million in upfront fees and milestones for the U.S. rights to the late-stage pain drug Diractin (ketoprofen in Transfersome gel),... Read more...

painkiller Press Releases

Common painkillers lower levels of prostate cancer biomarker

Latest Headlines

Alpharma's Embeda relieves pain in Phase III
September 10, 2008
Alpharma withdraws painkiller NDA
April 22, 2008
Abraxis buys Shimoda, subsidiary
April 4, 2008
Alpharma touts Phase III pain drug data
November 30, 2007
ALSO NOTED: Genzyme has made best offer for Bioenvision; Pfizer wants investigators to pursue ex-employee; GSK licenses IP; and
September 27, 2007
Alpharma sub inks $202M deal for pain drug
September 6, 2007
CeNeS licenses promising sedative to Ono
August 6, 2007
Press Release: Pain Therapeutics Announces Positive Phase I Study Results With PTI-202
November 28, 2006
Cephalon takes heat for off-label narcotic promotion
November 20, 2006
Labopharm shares sink on approvable letter
September 28, 2006
FDA whistle-blower attacks safety of Arcoxia
September 12, 2006
Investors cheer Lipitor patent decision
December 18, 2005
Pain Therapeutics' experimental painkiller flunks late-stage trial
November 21, 2005
FDA approves Biovail's tramadol ER
October 23, 2005
ALSO NOTED: DOV highlights painkiller data; Merck officials insist they can withstand legal onslaught; Amarin shares surge on t
September 11, 2005
Pain Therapeutics reports success in Phase III Remoxy trial
September 8, 2005
Biovail's once-daily Tramadol approved
September 8, 2005
Endo shares up on positive painkiller data
August 21, 2005
Purdue yanks Palladone on fears misuse could kill
July 13, 2005

Paid Research Reports